Ireland· IE-PA-PA0979/042/001
Strepsils Extra Blackcurrant Lozenges
A hexylresorcinol product containing hexylresorcinol, registered in Ireland by Reckitt Benckiser Ireland Limited. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hexylresorcinol is registered in 4 of 19 countries.
Countries holding a registration under ATC R02AA12 (hexylresorcinol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Hexylresorcinol · ATC R02AA12
4 / 19 countries
- Canada
- Ireland
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Hexylresorcinol
- Manufacturer
- Reckitt Benckiser Ireland Limited
- Country
- Ireland (IE)
- ATC code
- R02AA12
- ATC class
- Hexylresorcinol
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0979/042/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexylresorcinol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBenylin Sore Throat Honey and Lemon 2.4mg lozengesPfizer Consumer Healthcare Ltd
- United StatesMUCINEX INSTASOOTHEReckitt Benckiser LLC
- CanadaBRADOSOL LOZENGES EXTRA STRENGTH 3.5MGCOLUMBIA LABORATORIES CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Asda Dual Action Honey And Lemon Flavour Throat, Boots Sore Throat Relief Double Action Cherry Flavour
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66b8905a-1002-41c2-8866-ba8b11408e5f GET /v1/drugs/66b8905a-1002-41c2-8866-ba8b11408e5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Lozenge",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"R02AA12"
],
"strength": null,
"pa_number": "PA0979/042/001",
"substances": [
"Hexylresorcinol"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "10/06/2005",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through non-pharmacy outlets and pharmacies",
"interchangeable_code": null
}See everything about hexylresorcinol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.